查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1279917

2023-2030年全球學名藥市場規模研究與預測，按類型、按應用、按產品、按給藥途徑、按配銷通路和區域分析

Global Generic Pharmaceuticals Market Size study & Forecast, by Type, by Application, by Product, By Route of Administration, by Distribution Channel and Regional Analysis, 2023-2030
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

2022年全球學名藥市場價值約為3617億美元，預計在2022-2029年預測期內將以超過8.3%的健康成長率成長。學名藥是指在劑量、安全性、強度、給藥途徑、品質和預期用途方面與品牌藥相同或生物等效的藥物。學名藥是在原品牌藥物的專利權過期後生產的。這使得其他製藥公司能夠以較低的成本生產和銷售相同的藥物，因為不需要投資於創造新藥所需的昂貴的研究和開發。因為各種因素，如不斷上升、增加的ANDA批准和仿製產品的推出以及政府促進學名藥使用的計劃，學名藥市場日益擴大。

ANDA批准數量的上升和學名藥產品的推出是市場成長的原因。根據美國FDA的學名藥年度報告，ANDA批准的數量從2020年的948個增加到2021年的776個。此外，來自同一來源的報告指出，到2021年底，總體上有100個ANDA獲得批准。政府已經實施了計劃，為重要的學名藥企業提供了各種機會，以減少藥品的支出。作為一個例子，透過在2021年使用學名藥，美國政府節省了3.73億美元的醫藥費用。根據AAM的《2021年非專利藥和生物學名藥獲取和節約報告》，91%的處方是用非專利藥來填補的，這佔處方藥成本的18.2%。此外，疾病負擔的增加和老年人口的上升為市場創造有利的成長。然而，非專利藥的實際價格缺乏透明度，阻礙了市場的成長。

全球學名藥市場研究的主要地區包括亞太地區、北美、歐洲、拉丁美洲和世界其他地區。北美在收入方面占主導地位，由於存在關鍵的市場成長和該地區日益成長的疾病流行率，加上這些越來越多的有利的政府計劃，以及不斷增加的產品推出和對學名藥的需求，推動該地區的市場成長。而亞太地區在預測期內預計將以最高的年複合成長率成長，這是因為諸如老年病和目標人群的上升、產品開發合作數量的增加、主要參與者的地理擴張以及政府和非營利組織對市場空間的積極參與等因素。

該研究的目的是確定近年來不同領域和國家的市場規模，並預測未來幾年的價值。本報告旨在將研究涉及的國家內的產業的品質和數量方面都涵蓋其中。

本報告還提供了關於關鍵方面的詳細資訊，如驅動因素和挑戰，這將確定市場的未來成長。此外，還涵蓋了微觀市場的潛在機會，供利益相關者投資，並詳細分析了競爭格局和主要參與者的產品。

目錄

第一章：執行摘要

  • 市場簡介
  • 2020-2030年全球和細分市場的估計和預測
    • 2020-2030年，學名藥市場，按地區分類
    • 2020-2030年，學名藥市場，按類型分類
    • 2020-2030年，學名藥市場，按應用分類
    • 2020-2030年，學名藥市場，按產品分類
    • 2020-2030年，學名藥市場，按給藥途徑分類
    • 2020-2030年，學名藥市場，按配銷通路分類
  • 主要趨勢
  • 估算方法
  • 研究假設

第二章：全球學名藥市場的定義和範圍

  • 本研究的目的
  • 市場定義和範圍
    • 產業演變
    • 研究的範圍
  • 研究涵蓋的年份
  • 貨幣兌換率

第三章：全球學名藥市場動態

  • 學名藥市場影響分析（2020-2030年）
    • 市場驅動力
      • 越來越多的ANDA批准和非專利產品的推出
      • 政府採取措施促進學名藥的使用
    • 市場挑戰
      • 學名藥的高成本
      • 定價問題
    • 市場機會
      • 不斷增加的疾病負擔
      • 老年人口不斷增加

第四章：全球學名藥市場產業分析

  • 波特的五力模型
    • 供應商的議價能力
    • 買方的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭性的競爭
  • 波特五力影響分析
  • PEST分析
    • 政治
    • 經濟
    • 社會
    • 技術
    • 環境
    • 法律問題
  • 最佳投資機會
  • 最佳策略
  • COVID-19影響分析
  • 顛覆性趨勢
  • 產業專家的觀點
  • 分析師建議與結論

第五章：全球學名藥市場，按類型分類

  • 市場簡介
  • 按類型分類的全球學名藥市場，性能-潛力分析
  • 2020-2030年全球學名藥市場按類型的估計和預測
  • 學名藥市場，細項分析
    • 簡單學名藥
    • 特殊學名藥
    • 生物學名藥

第六章：全球學名藥市場，按應用分類

  • 市場簡介
  • 按應用分類的全球學名藥市場，表現- 潛力分析
  • 2020-2030年全球學名藥市場按應用的估計和預測
  • 學名藥市場，細項分析
    • 中樞神經系統疾病
    • 呼吸系統疾病
    • 激素及相關疾病
    • 胃腸道疾病
    • 心血管疾病
    • 傳染性疾病
    • 其他疾病

第7章：全球學名藥市場，按產品分類

  • 市場簡介
  • 按產品分類的全球學名藥市場，表現- 潛力分析
  • 2020-2030年全球學名藥市場按產品的估計和預測
  • 學名藥市場，子區隔分析
    • 小分子
    • 大分子

第8章：按給藥途徑分類的全球學名藥市場

  • 市場簡介
  • 按給藥途徑分類的全球學名藥市場，表現- 潛力分析
  • 2020-2030年按給藥途徑分類的全球學名藥市場估計和預測
  • 學名藥市場，子區隔分析
    • 口服
    • 注射式
    • 吸入式
    • 其他途徑

第九章：全球學名藥市場，按配銷通路分類

  • 市場簡介
  • 按配銷通路分類的全球學名藥市場，表現- 潛力分析
  • 2020-2030年全球學名藥市場按配銷通路的估計和預測
  • 學名藥市場，次級細分市場分析
    • 網上藥店
    • 零售藥店
    • 醫院藥店

第十章：全球學名藥市場，區域分析

  • 最領先的國家
  • 新興國家
  • 學名藥市場，區域市場簡介
  • 北美洲
    • 美國
      • 2020-2030年類型細分的估計和預測
      • 2020-2030年應用細分的估計和預測
      • 2020-2030年產品細分的估計和預測
      • 2020-2030年給藥途徑分類估計和預測
      • 2020-2030年配銷通路細分的估計和預測
    • 加拿大
  • 歐洲學名藥市場概況
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區學名藥市場概況
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 亞太其他地區
  • 拉丁美洲學名藥市場簡況
    • 巴西
    • 墨西哥
  • 世界其他地區

第十一章：競爭情報

  • 主要公司SWOT分析
    • 公司1
    • 公司2
    • 公司3
  • 頂級市場戰略
  • 公司簡介
    • Teva Pharmaceutical Industries Ltd.
      • 關鍵資訊
      • 概況
      • 財務（取決於資料的可用性）
      • 產品摘要
      • 最近的發展情況
    • Viatris Inc.
    • Novartis AG
    • Sun Pharmaceutical Industries Ltd.
    • LUPIN
    • AbbVie Inc. (Allergan)
    • AstraZeneca
    • Sawai Pharmaceutical Co., Ltd.
    • Hikma Pharmaceuticals PLC
    • Dr. Reddy's Laboratories Ltd.

第十二章：研究過程

  • 研究過程
    • 資料探勘
    • 分析
    • 市場評估
    • 驗證
    • 出版
  • 研究屬性
  • 研究假設

Global Generic Pharmaceuticals Market is valued at approximately USD 361.7 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 8.3% over the forecast period 2022-2029. Generic pharmaceuticals are medications that are identical, or bioequivalent, to brand-name drugs in terms of dosage, safety, strength, route of administration, quality, and intended use. Generic drugs are produced after the patent for the original brand-name drug has expired. This allows other pharmaceutical companies to manufacture and sell the same medication at a lower cost because they do not need to invest in the costly research and development that is required to create a new drug. The Generic Pharmaceuticals market is expanding because of factors such as rising, increasing ANDA approval and generic product launches and government initiatives to promote the usage of generics.

The rise in the number of ANDA approvals and generic medication product launches accounts for the market growth. according to the U.S. FDA's Generic Drugs Annual report, the number of ANDA approvals increased from 948 in 2020 to 776 in 2021. Additionally, from the same source, it was reported that 100 ANDAs had been approved overall by the end of 2021. Governments have implemented programs that offer various opportunities for significant generic drug players to cut back on expenditure on pharmaceuticals. As an illustration, by using generic medications in 2021, the U.S. government saved USD 373 million on pharmaceutical costs. According to the AAM Generic Drug & Biosimilars Access & Savings Report 2021, 91% of prescriptions are filled with generic medication, which represents 18.2% of prescription drug costs. In addition, the increasing Disease Burden and Rising Geriatric Population are creating lucrative growth in the market. However, a lack of transparency about the actual price of generic drugs hampers the market growth.

The key regions considered for the Global Generic Pharmaceuticals Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the presence of key market growth and the region's increasing disease prevalence, along with these increasing number of favorable government initiatives coupled with the rising number of product launches and demand for a generic drug is driving the market growth in the region. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market players included in this report are:

  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Novartis AG
  • Sun Pharmaceutical Industries Ltd.
  • LUPIN
  • AbbVie Inc. (Allergan)
  • AstraZeneca
  • Sawai Pharmaceutical Co., Ltd.
  • Hikma Pharmaceuticals PLC
  • Dr. Reddy's Laboratories Ltd.

Recent Developments in the Market:

  • In January 2022, the Mark Cuban Cost Plus Drugs Company (MCCPDC) announced the launch of an online pharmacy. The pharmacy would offer around more than 100 generic drugs at a low cost to patients.

Global Generic Pharmaceuticals Market Report Scope:

  • Historical Data: - 2020 - 2021
  • Base Year for Estimation: - 2022
  • Forecast period: - 2023-2030
  • Report Coverage: - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: - Type, Application, Product, Application, Route of Administration, Distribution Channel, Region
  • Regional Scope: - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Type:

  • Simple Generics
  • Specialty Generics
  • Biosimilars

By Application:

  • Central Nervous System Disorders
  • Respiratory Diseases
  • Hormones & Related Diseases
  • Gastrointestinal Diseases
  • Cardiovascular Diseases
  • Infectious Diseases
  • Others

By Product:

  • Small Molecule
  • Large Molecule

By Route of Administration:

  • Oral
  • Injectable
  • Inhalable
  • Others

Distribution Channel:

  • Online Pharmacies
  • Hospitals Pharmacies
  • Retail Pharmacies

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Generic Pharmaceuticals Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Generic Pharmaceuticals Market, by Type, 2020-2030 (USD Billion)
    • 1.2.3. Generic Pharmaceuticals Market, by Application, 2020-2030 (USD Billion)
    • 1.2.4. Generic Pharmaceuticals Market, by Product, 2020-2030 (USD Billion)
    • 1.2.5. Generic Pharmaceuticals Market, by Route of Administration, 2020-2030 (USD Billion)
    • 1.2.6. Generic Pharmaceuticals Market, by Distribution Channel, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Generic Pharmaceuticals Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Generic Pharmaceuticals Market Dynamics

  • 3.1. Generic Pharmaceuticals Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing ANDA approval and Generic Product Launches
      • 3.1.1.2. Government initiatives to promote usage of generics
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Generic Pharmaceuticals
      • 3.1.2.2. Pricing issues
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing Disease Burden
      • 3.1.3.2. Rising Geriatric Population

Chapter 4. Global Generic Pharmaceuticals Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Generic Pharmaceuticals Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global Generic Pharmaceuticals Market by Type, Performance - Potential Analysis
  • 5.3. Global Generic Pharmaceuticals Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
  • 5.4. Generic Pharmaceuticals Market, Sub Segment Analysis
    • 5.4.1. Simple Generics
    • 5.4.2. Specialty Generics
    • 5.4.3. Biosimilars

Chapter 6. Global Generic Pharmaceuticals Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Generic Pharmaceuticals Market by Application, Performance - Potential Analysis
  • 6.3. Global Generic Pharmaceuticals Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 6.4. Generic Pharmaceuticals Market, Sub Segment Analysis
    • 6.4.1. Central Nervous System Disorders
    • 6.4.2. Respiratory Diseases
    • 6.4.3. Hormones & Related Diseases
    • 6.4.4. Gastrointestinal Diseases
    • 6.4.5. Cardiovascular Diseases
    • 6.4.6. Infectious Diseases
    • 6.4.7. Others

Chapter 7. Global Generic Pharmaceuticals Market, by Product

  • 7.1. Market Snapshot
  • 7.2. Global Generic Pharmaceuticals Market by Product, Performance - Potential Analysis
  • 7.3. Global Generic Pharmaceuticals Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
  • 7.4. Generic Pharmaceuticals Market, Sub Segment Analysis
    • 7.4.1. Small Molecule
    • 7.4.2. Large Molecule

Chapter 8. Global Generic Pharmaceuticals Market, by Route of Administration

  • 8.1. Market Snapshot
  • 8.2. Global Generic Pharmaceuticals Market by Route of Administration, Performance - Potential Analysis
  • 8.3. Global Generic Pharmaceuticals Market Estimates & Forecasts by Route of Administration 2020-2030 (USD Billion)
  • 8.4. Generic Pharmaceuticals Market, Sub Segment Analysis
    • 8.4.1. Oral
    • 8.4.2. Injectable
    • 8.4.3. Inhalable
    • 8.4.4. Others

Chapter 9. Global Generic Pharmaceuticals Market, by Distribution Channel

  • 9.1. Market Snapshot
  • 9.2. Global Generic Pharmaceuticals Market by Distribution Channel, Performance - Potential Analysis
  • 9.3. Global Generic Pharmaceuticals Market Estimates & Forecasts by Distribution channel 2020-2030 (USD Billion)
  • 9.4. Generic Pharmaceuticals Market, Sub Segment Analysis
    • 9.4.1. Online Pharmacies
    • 9.4.2. Retail Pharmacies
    • 9.4.3. Hospital Pharmacies

Chapter 10. Global Generic Pharmaceuticals Market, Regional Analysis

  • 10.1. Top Leading Countries
  • 10.2. Top Emerging Countries
  • 10.3. Generic Pharmaceuticals Market, Regional Market Snapshot
  • 10.4. North America Generic Pharmaceuticals Market
    • 10.4.1. U.S. Generic Pharmaceuticals Market
      • 10.4.1.1. Type breakdown estimates & forecasts, 2020-2030
      • 10.4.1.2. Application breakdown estimates & forecasts, 2020-2030
      • 10.4.1.3. Product breakdown estimates & forecasts, 2020-2030
      • 10.4.1.4. Route of Administration breakdown estimates & forecasts, 2020-2030 10.4.1.5. Distribution Channel breakdown estimates & forecasts, 2020-2030
    • 10.4.2. Canada Generic Pharmaceuticals Market
  • 10.5. Europe Generic Pharmaceuticals Market Snapshot
    • 10.5.1. U.K. Generic Pharmaceuticals Market
    • 10.5.2. Germany Generic Pharmaceuticals Market
    • 10.5.3. France Generic Pharmaceuticals Market
    • 10.5.4. Spain Generic Pharmaceuticals Market
    • 10.5.5. Italy Generic Pharmaceuticals Market
    • 10.5.6. Rest of Europe Generic Pharmaceuticals Market
  • 10.6. Asia-Pacific Generic Pharmaceuticals Market Snapshot
    • 10.6.1. China Generic Pharmaceuticals Market
    • 10.6.2. India Generic Pharmaceuticals Market
    • 10.6.3. Japan Generic Pharmaceuticals Market
    • 10.6.4. Australia Generic Pharmaceuticals Market
    • 10.6.5. South Korea Generic Pharmaceuticals Market
    • 10.6.6. Rest of Asia Pacific Generic Pharmaceuticals Market
  • 10.7. Latin America Generic Pharmaceuticals Market Snapshot
    • 10.7.1. Brazil Generic Pharmaceuticals Market
    • 10.7.2. Mexico Generic Pharmaceuticals Market
  • 10.8. Rest of The World Generic Pharmaceuticals Market

Chapter 11. Competitive Intelligence

  • 11.1. Key Company SWOT Analysis
    • 11.1.1. Company 1
    • 11.1.2. Company 2
    • 11.1.3. Company 3
  • 11.2. Top Market Strategies
  • 11.3. Company Profiles
    • 11.3.1. Teva Pharmaceutical Industries Ltd.
      • 11.3.1.1. Key Information
      • 11.3.1.2. Overview
      • 11.3.1.3. Financial (Subject to Data Availability)
      • 11.3.1.4. Product Summary
      • 11.3.1.5. Recent Developments
    • 11.3.2. Viatris Inc.
    • 11.3.3. Novartis AG
    • 11.3.4. Sun Pharmaceutical Industries Ltd.
    • 11.3.5. LUPIN
    • 11.3.6. AbbVie Inc. (Allergan)
    • 11.3.7. AstraZeneca
    • 11.3.8. Sawai Pharmaceutical Co., Ltd.
    • 11.3.9. Hikma Pharmaceuticals PLC
    • 11.3.10. Dr. Reddy's Laboratories Ltd.

Chapter 12. Research Process

  • 12.1. Research Process
    • 12.1.1. Data Mining
    • 12.1.2. Analysis
    • 12.1.3. Market Estimation
    • 12.1.4. Validation
    • 12.1.5. Publishing
  • 12.2. Research Attributes
  • 12.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Generic Pharmaceuticals Market, report scope
  • TABLE 2. Global Generic Pharmaceuticals Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Generic Pharmaceuticals Market estimates & forecasts by Type 2020-2030 (USD Billion)
  • TABLE 4. Global Generic Pharmaceuticals Market estimates & forecasts by Application 2020-2030 (USD Billion)
  • TABLE 5. Global Generic Pharmaceuticals Market estimates & forecasts by Product 2020-2030 (USD Billion)
  • TABLE 6. Global Generic Pharmaceuticals Market estimates & forecasts by Route of Administration 2020-2030 (USD Billion)
  • TABLE 7. Global Generic Pharmaceuticals Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
  • TABLE 8. Global Generic Pharmaceuticals Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Generic Pharmaceuticals Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Generic Pharmaceuticals Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Generic Pharmaceuticals Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Generic Pharmaceuticals Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Generic Pharmaceuticals Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Generic Pharmaceuticals Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Generic Pharmaceuticals Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. Global Generic Pharmaceuticals Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. Global Generic Pharmaceuticals Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 18. U.S. Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 19. U.S. Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 20. U.S. Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. Canada Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 22. Canada Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 23. Canada Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. UK Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 25. UK Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 26. UK Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. Germany Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 28. Germany Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 29. Germany Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. France Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 31. France Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 32. France Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Italy Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 34. Italy Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 35. Italy Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. Spain Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 37. Spain Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 38. Spain Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. RoE Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 40. RoE Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 41. RoE Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. China Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 43. China Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 44. China Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. India Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 46. India Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 47. India Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. Japan Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 49. Japan Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 50. Japan Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. South Korea Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 52. South Korea Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 53. South Korea Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. Australia Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 55. Australia Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 56. Australia Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 58. RoAPAC Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 59. RoAPAC Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Brazil Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 61. Brazil Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 62. Brazil Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. Mexico Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 64. Mexico Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 65. Mexico Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. RoLA Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 67. RoLA Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 68. RoLA Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. Saudi Arabia Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 70. South Africa Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 71. RoMEA Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 72. List of secondary sources, used in the study of global Generic Pharmaceuticals Market
  • TABLE 73. List of primary sources, used in the study of global Generic Pharmaceuticals Market
  • TABLE 74. Years considered for the study
  • TABLE 75. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Generic Pharmaceuticals Market, research methodology
  • FIG 2. Global Generic Pharmaceuticals Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Generic Pharmaceuticals Market, key trends 2022
  • FIG 5. Global Generic Pharmaceuticals Market, growth prospects 2023-2030
  • FIG 6. Global Generic Pharmaceuticals Market, porters 5 force model
  • FIG 7. Global Generic Pharmaceuticals Market, pest analysis
  • FIG 8. Global Generic Pharmaceuticals Market, value chain analysis
  • FIG 9. Global Generic Pharmaceuticals Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Generic Pharmaceuticals Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Generic Pharmaceuticals Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Generic Pharmaceuticals Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Generic Pharmaceuticals Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Generic Pharmaceuticals Market, regional snapshot 2020 & 2030
  • FIG 15. North America Generic Pharmaceuticals Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Generic Pharmaceuticals Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Generic Pharmaceuticals Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Generic Pharmaceuticals Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Generic Pharmaceuticals Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable